Prostate cancer is a cancer that starts in the prostate gland. It is the third most common cause of death from cancer in men of all ages and is the most common cause of death from cancer in men over the age of 75. Prostate cancer is rarely found in men younger than 40. More than 1.1 million cases of prostate cancer were recorded in 2012 worldwide, accounting for approximately 8 percent of all new cancer cases and 15 percent in men. In 2018, the American Cancer Society predicts that there will be around 164,690 new diagnoses of prostate cancer, and that around 29,430 fatalities will occur because of it in the United States.
Prostate cancer is a cancer that starts in the prostate gland. It is the third most common cause of death from cancer in men of all ages and is the most common cause of death from cancer in men over the age of 75. Prostate cancer is rarely found in men younger than 40. More than 1.1 million cases of prostate cancer were recorded in 2012 worldwide, accounting for approximately 8 percent of all new cancer cases and 15 percent in men. In 2018, the American Cancer Society predicts that there will be around 164,690 new diagnoses of prostate cancer, and that around 29,430 fatalities will occur because of it in the United States. Treatment is different for early and advanced prostate cancers. In early stage prostate cancer, If the cancer is small and localized, it is usually managed by one of the following treatments: Watchful waiting or monitoring, based on PSA blood levels; Radical prostatectomy where the prostate is surgically removed; Brachytherapy using radioactive seeds that are implanted into the prostate to deliver targeted radiation treatment; Conformal radiation therapy; and Intensity modulated radiation therapy. Patients may receive radiation therapy combined with hormone therapy for 4 to 6 months.

Read More